Edwards Lifesciences Corp (EW)

EW (NYSE:Health Services) EQUITY
$130.95
neg -7.40
-5.30%
Today's Range: 130.53 - 139.42 | EW Avg Daily Volume: 987,700
Last Update: 04/27/15 - 3:59 PM EDT
Volume: 1,410,571
YTD Performance: 11.41%
Open: $139.22
Previous Close: $138.33
52 Week Range: $78.12 - $150.41
Oustanding Shares: 107,839,918
Market Cap: 15,259,789,050
6-Month Chart
TheStreet Ratings Grade for EW
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 0 0 0 0
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.94 1.94 1.94 1.94
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 18.97
Price Earnings Comparisons:
EW Sector Avg. S&P 500
18.97 19.00 28.22
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.48% 73.09% 93.46%
GROWTH 12 Mo 3 Yr CAGR
Revenue 13.60 0.38 0.11
Net Income 107.10 2.43 0.50
EPS 117.20 2.68 0.54
Earnings for EW:
EBITDA 0.56B
Revenue 2.32B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.05 $0.98 $4.23 $4.78
Number of Analysts 9 10 12 13
High Estimate $1.08 $1.04 $4.30 $5.15
Low Estimate $0.97 $0.93 $4.13 $4.32
Prior Year $0.88 $0.80 $3.50 $4.23
Growth Rate (Year over Year) 18.94% 22.25% 20.88% 12.91%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Apr 6, 2015 | 10:40 AM EDT

There are dozens of juicy opportunities in this market.

By

Jim Cramer

 | Mar 16, 2015 | 11:57 AM EDT

It shouldn't be possible, but it never seems too late to get in.

By

Jim Cramer

 | Feb 19, 2015 | 7:36 AM EST

A lot of stocks are doing incredibly well. 

By

Jim Cramer

 | Feb 17, 2015 | 1:54 PM EST

Cybersecurity, retail among the most fashionable.

By

Jim Cramer

 | Feb 4, 2015 | 2:06 PM EST

The 'dead bodies' are adding up.

By

Jim Cramer

 | Dec 22, 2014 | 7:00 AM EST

Throughout this historic run, four groups have consistently led the market.

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

bullishEdwards Lifesciences numbers increased at BMO

Dec 9, 2014 | 7:43 AM EST

EW estimates were raised through 2016, BMO Capital said. Management boosted guidance. Market Perform rating and new $135 price target. 

bullishEdwards Lifesciences estimates, price target raised at Barclays

Dec 9, 2014 | 7:32 AM EST

EW price target raised to $100 from $92, said Barclays. Following analyst day, market growth and EPS estimates raised. 

bullishEdwards Lifesciences price target raised at Leerink

Dec 1, 2014 | 8:08 AM EST

EW price target raised to $142 from $125, said Leerink. Model updated to reflect modest changes in Transcatheter Aortic Valve Replacement sales, while Europe growth figures reduced conservatively. Rating remains Outperform.

Points well taken.

Hi Doug, your point is well taken - it's true that the relationship between the dollar and...
Hard to tell as Beats is lumped in with iPod and Apple TV -- but stripping away weak sales...

Okay, $140 billion? That's just sick lol.

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.